Primemd Stock Performance
| PRMD Stock | USD 0.0005 0.0002 66.67% |
Primemd holds a performance score of 10 on a scale of zero to a hundred. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Primemd are completely uncorrelated. Use Primemd daily balance of power , to analyze future returns on Primemd.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Primemd are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile primary indicators, Primemd exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Primemd |
Primemd Relative Risk vs. Return Landscape
If you would invest 0.03 in Primemd on September 25, 2025 and sell it today you would earn a total of 0.02 from holding Primemd or generate 66.67% return on investment over 90 days. Primemd is currently generating 1.0582% in daily expected returns and assumes 8.3992% risk (volatility on return distribution) over the 90 days horizon. In different words, 75% of pink sheets are less volatile than Primemd, and 79% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Primemd Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Primemd's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Primemd, and traders can use it to determine the average amount a Primemd's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.126
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | PRMD | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Primemd is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Primemd by adding it to a well-diversified portfolio.
Primemd Fundamentals Growth
Primemd Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Primemd, and Primemd fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Primemd Pink Sheet performance.
| Return On Equity | -0.0685 | |||
| Return On Asset | -0.0182 | |||
| Profit Margin | (1.17) % | |||
| Operating Margin | (0.58) % | |||
| Current Valuation | 76.82 K | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 0.47 X | |||
| Revenue | 69.98 K | |||
| EBITDA | (36.75 K) | |||
| Cash And Equivalents | 435.5 K | |||
| Cash Per Share | 0.14 X | |||
| Book Value Per Share | 0.38 X | |||
| Cash Flow From Operations | (90.82 K) | |||
| Earnings Per Share | (0.03) X | |||
About Primemd Performance
By analyzing Primemd's fundamental ratios, stakeholders can gain valuable insights into Primemd's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Primemd has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Primemd has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Primemd Inc., together with its subsidiaries, is engaged in the purchase and development of residential and commercial real estate properties in the United States. The company was formerly known as Eagle Exploration Co. and changed its name to Primemd Inc. in June 2021. Primemd is traded on OTC Exchange in the United States.Things to note about Primemd performance evaluation
Checking the ongoing alerts about Primemd for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Primemd help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Primemd is way too risky over 90 days horizon | |
| Primemd has some characteristics of a very speculative penny stock | |
| Primemd appears to be risky and price may revert if volatility continues | |
| Primemd has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 69.98 K. Net Loss for the year was (101.12 K) with profit before overhead, payroll, taxes, and interest of 67.8 K. | |
| Primemd currently holds about 435.5 K in cash with (90.82 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Primemd's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Primemd's stock is overvalued or undervalued compared to its peers.
- Examining Primemd's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Primemd's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Primemd's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Primemd's pink sheet. These opinions can provide insight into Primemd's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Primemd Pink Sheet analysis
When running Primemd's price analysis, check to measure Primemd's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Primemd is operating at the current time. Most of Primemd's value examination focuses on studying past and present price action to predict the probability of Primemd's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Primemd's price. Additionally, you may evaluate how the addition of Primemd to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |